Sadikova N.G, Najmutdinova D. K, Urunbayeva D. A, Alimova S. E, & Tillaboyev Sh.Sh. (2023). Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin). Genius Repository, 26, 1–4. Retrieved from https://geniusrepo.net/index.php/1/article/view/277